版本:
中国

公司新闻: 浙江华海药业股份有限公司 (600521.SS)

600521.SS ( 上海证券交易所 )

15.65CNY
11:29 BJT
涨跌 (%)

¥-0.24 (-1.51%)
收盘
¥15.89
开盘
¥15.50
当日最高
¥15.88
当日最低
¥15.44
成交量
8,140,396
平均成交量
11,447,115
52 周最高
¥22.20
52 周最低
¥9.80

选择日期:

UPDATE 2-FDA approves generic valsartan amid drug shortage

March 12 The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages triggered by several manufacturers recalling the drug over possible cancer risk. 全文

UPDATE 3-New cancer-causing toxin found in recalled blood pressure pills

March 1 U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly used drugs to treat hypertension. 全文

UPDATE 3-New cancer-causing toxin found in recalled blood pressure pills

March 1 U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly used drugs to treat hypertension. 全文

CORRECTED-UPDATE 1-New cancer-causing toxin found in recalled blood pressure pills

March 1 U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly-used drugs to treat hypertension. 全文

选择另外日期:

公司公告